- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04886219
Studies of the Angle Kappa and the Angle Alpha (EKAPS)
Studies of the Characteristics of the Angle Kappa and the Angle Alpha in the Healthy Individual. Studies of the Angle Kappa and the Angle Alpha
Anatomical ophthalmological connections and their dynamics are still debated in the scientific community. However, their considering is essential in many surgeries (strabismus, cataract, refractive...) or in clinical practice.
The correlation between these biometric values would make it possible to refine the knowledge related to these landmarks and thus offer better ophthalmological management by integrating these variables into the clinical examination.
The aim of the study is to analyze the correlation between the angle alpha and the angle kappa in a healthy individual without ophthalmologic disorder.
Study Overview
Detailed Description
The angle kappa corresponds to the angle formed between the visual axis (line between the point of fixation and the fovea: area of the retina allowing precise vision) and the pupillary axis (line passing through the center of the pupil and perpendicular to the cornea). The angle alpha corresponds to the angle formed between the visual axis and the optical axis (line passing through the nodal point of the eye and corneal center).
In theory, the angle kappa and angle alpha are equal; but physiological corectopy in the nasal position induces a variation between these two angles; the angle kappa being generally less than the angle alpha without a correlation being established. Also, pupillary constriction causes a variation in the position of the center of the pupil. The angle kappa therefore exhibits a variation depending on the expansion.
Anatomical ophthalmological connections and their dynamics are still debated in the scientific community. However, their considering is essential in many surgeries (strabismus, cataract, refractive ...) or in clinical practice.
The correlation between these biometric values would make it possible to refine the knowledge related to these landmarks and thus offer better ophthalmological management by integrating these variables into the clinical examination.
The aim of the study is to analyze the correlation between the angle alpha and the angle kappa in a healthy individual without an eye disorder.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75015
- Hôpital Necker-Enfants Malades
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Informed major subject not opposing to their participation in the study
Exclusion Criteria:
- Subject with strabismus or organic ophthalmologic pathology
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy individual
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Value of the angle Kappa
Time Frame: Day 0
|
Semi-automatic digital method of measurement by eye photography
|
Day 0
|
Value of the angle Alpha
Time Frame: Day 0
|
Semi-automatic digital method of measurement by eye photography
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variation of the Kappa angle depending on the pupillary diameter
Time Frame: Day 0
|
Variation in the same individual.
Value of the Kappa angle using the semi-automatic method of measurement by ocular photography in photopic and scotopic conditions & measurement of the pupillary diameter using the photographs obtained
|
Day 0
|
Correlation between the value of the angle Alpha and the Optic disc / fovea distance
Time Frame: Day 0
|
Angle Alpha value using the semi-automatic method of measurement by eye photography and the distance between the optic disc and the fovea
|
Day 0
|
Correlation between the angle Kappa and the axial length
Time Frame: Day 0
|
Value of the angle Kappa and Alpha using the semi-automatic method of measurement by eye photography and Value of the axial length measured by biometry IolMaster 500 (Carl Zeiss)
|
Day 0
|
Collaborators and Investigators
Investigators
- Principal Investigator: Maxence Rateaux, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210289
- 2020-A03370-39 (OTHER: IDRCB number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on No Eye Disorder
-
Assistance Publique - Hôpitaux de ParisCompleted
-
OptovueCompletedNo Eye DiseaseUnited States, United Kingdom
-
UPECLIN HC FM Botucatu UnespUnknownAdult | Inclusion Criteria: | No Pregnancy | No Lactation | No MorbidityBrazil
-
Universidad Católica San Antonio de MurciaUniversidad de AlmeriaActive, not recruitingAdults | No Sagittal Spine Disposition Disorder | No Surgery on the Spine or the Hamstring | No Specific Treatment for Spinal Pathology | Not Involved in Structured Exercise Programs Before or During the Time of the StudySpain
-
Medical University of ViennaRecruitingLens Luxation | IOL Subluxation | IOL Opacification | Aphakia - No Lens CapsuleAustria
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Zambon SpACompleted
-
Sheba Medical CenterTel Aviv UniversityRecruiting
Clinical Trials on Eye examination
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Colorado, DenverTerminated
-
Zhongnan HospitalRecruitingDry Eye | MGD-Meibomian Gland DysfunctionChina
-
Direction Centrale du Service de Santé des ArméesCompleted
-
University of Texas Southwestern Medical CenterDallas VA Research CorporationWithdrawn
-
Charles Drew University of Medicine and ScienceUniversity of California, Los Angeles; National Library of Medicine (NLM); Los...Active, not recruitingDiabetic Retinopathy | Diabetic Macular EdemaUnited States
-
MeddocRecruiting
-
University of MichiganCompletedAlzheimer Disease | Frontotemporal Dementia | Alzheimer DementiaUnited States
-
Rebiscan, Inc.Kaiser Foundation Research InstituteCompletedStrabismus | AmblyopiaUnited States
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruiting